androgen deprivation therapy and cardiovascular risk

نویسندگان

panagiotis mourmouris department of urology, school of medicine, wo{e~o

yoogeouzenslosy{}anog}oovgwmvylonostiuo, greece +30-2108044703, [email protected]

eleni efstathiou department of clinical therapeutics / oncology, school of medicine, university of athens, alexandra hospital, greece

athanasios papatsoris department of urology, school of medicine, wo{e~o

چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Androgen Deprivation Therapy and Cardiovascular Risk

PURPOSE The potential association between androgen deprivation therapy (ADT) and cardiovascular mortality (CVM) remains controversial. This study assessed mortality outcomes in a large national registry to further elucidate the association between treatment selection and cause of mortality. PATIENTS AND METHODS A total of 7,248 men in the CaPSURE registry were analyzed. Treatment was categori...

متن کامل

Cardiovascular risk associated with androgen deprivation therapy.

Prostate cancer is the second leading cause of cancer-related death among men in the United States.[1] Androgen deprivation therapy (ADT) is a common treatment for prostate cancer. ADT includes gonadotropin-releasing hormone (GnRH) agonists (leuprolide, goserelin, triptorelin), bilateral orchiectomy, and anti-androgen receptor blockers such as flutamide and bicalutamide. Several studies have no...

متن کامل

Cardiovascular risks of androgen deprivation therapy.

Prostate adenocarcinoma is the most common cancer type in the male sex after skin cancer. Among the several types of treatment for prostate cancer, the androgen deprivation therapy has been highly recommended in patients with metastatic or locally advanced disease, which probably results in increased survival. However, the androgen deprivation is the cause of several adverse effects. Complicati...

متن کامل

Androgen Deprivation Therapy–Induced Cardiovascular Disease

Why did the patients who underwent orchidectomy have statistically significantly higher prostatespecific antigen? It would have been informative if we had the baseline glucose, lipid profile, and indices of obesity for patients receiving ADT to show that their cardiovascular risk factors definitely increased with ADT. As there is a definite increase in cardiovascular risk factors with ADT, we s...

متن کامل

Re: androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.

[2] Turner KJ, Brewster SF. Rectal examination and urethral catheterization by medical students and house offices: taught but not used. BJU Int 2000;86:422–6. [3] Philip J, Dutta RS, Ballal M, et al. Is a digital rectal examination necessary in the diagnosis and clinical staging of early prostate cancer? BJU Int 2005;95:969–71. [4] Schroder FH, Roobol-Bouts M, Vis AN, Vanderkwast T, Krause R. P...

متن کامل

Risk and timing of cardiovascular disease after androgen-deprivation therapy in men with prostate cancer.

PURPOSE Findings on the association between risk of cardiovascular disease (CVD) and the duration and type of androgen-deprivation therapy (ADT) in men with prostate cancer (PCa) are inconsistent. METHODS By using data on filled drug prescriptions in Swedish national health care registers, we investigated the risk of CVD in a cohort of 41,362 men with PCa on ADT compared with an age-matched, ...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
nephro-urology monthly

جلد ۵، شماره ۱، صفحات ۶۵۳-۶۵۴

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023